Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06078527 · ClinicalTrials.gov registry record · NA
Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort
A NA study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT06078527 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 40 participants.
The verdict
NCT06078527, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
A previous study completed in 2022 (NCT05158179) was conducted using cohorts of healthy controls, and adults with general laryngopharyngeal disorders. This study will expand on the previous research to include a separate cohort of adults being seen in clinic for an existing laryngopharyngeal disorder resulting from previous radiation or other cancer treatments.
Interventions
- OTHER Questionnaires
- DEVICE Cheung-Bearelly Aesthesiometer
- PROCEDURE Transnasal Laryngoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06078527
The ClinicalTrials.gov registry entry for NCT06078527 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT06078527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06078527 about?
NCT06078527 is a clinical study titled "Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort". A previous study completed in 2022 (NCT05158179) was conducted using cohorts of healthy controls, and adults with general laryngopharyngeal disorders. This study will expand on the previous research to include a separate cohort of adults being seen in clinic for an existing laryngopharyngeal disorde...
What is the current status of trial NCT06078527?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-10-01. Estimated completion is 2028-01-31.
What interventions are being tested in trial NCT06078527?
The interventions under investigation include: Questionnaires (OTHER), Cheung-Bearelly Aesthesiometer (DEVICE), Transnasal Laryngoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT06078527?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.